BRCP:乳腺癌抵抗蛋白
“乳腺癌抵抗蛋白”(Breast Cancer Resistance Protein)在医学领域中常被缩写为BCRP,以方便在书面和口头交流中快捷使用。这一术语在英国及其他英语国家的医学文献和临床实践中尤为常见,它指的是一种与癌细胞对化疗药物产生耐药性密切相关的转运蛋白。深入研究BCRP的功能机制,对于制定更有效的乳腺癌治疗方案具有重要意义。
breast cancer resistance protein具体释义
breast cancer resistance protein的英文发音
例句
- In Vivo Experimental Study on Reversion of Multidrug-resistance of Hepatocellular Carcinoma by Suppression of Breast Cancer Resistance Protein Gene
- 抑制乳腺癌耐药蛋白基因逆转肝癌多药耐药的体内实验
- Interfering Breast Cancer Resistance Protein ( BCRP ) Gene for Reversing the Multidrug Resistance of Hepatocellular Carcinoma
- 反义核酸逆转乳腺癌细胞多药耐药的研究抑制乳腺癌耐药蛋白表达逆转肝细胞癌多药耐药
- Reverse multidrug resistance of hepatocellular carcinoma by suppressing breast cancer resistance protein(BRCP) gene
- 抑制BCRP表达逆转肝细胞癌MDR的研究
- Relationship between breast cancer resistance protein(BRCP) and response to platinum-based chemotherapy as well as prognosis in advanced non-small cell lung cancer
- 乳腺癌耐药蛋白表达与晚期非小细胞肺癌铂类为主的化疗疗效及预后的关系
- Expression of Breast Cancer Resistance Protein Gene in Breast Cancer Patients and Its Value in Evaluating the Therapeutic Effect of Chemotherapy for Breast Cancer
- 乳腺癌耐药蛋白基因在乳腺癌中的表达及其与化疗疗效的关系
本站英语缩略词为个人收集整理,可供非商业用途的复制、使用及分享,但严禁任何形式的采集或批量盗用
若BRCP词条信息存在错误、不当之处或涉及侵权,请及时联系我们处理:675289112@qq.com。